Exelixis Inc Revenues
Exelixis Inc (EXEL) reported Revenues of $231.09 million for the 3-month period ending 2020-10-02, per its 10-Q filed 2020-11-05.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2020-11-05
- Exelixis Inc revenues for the quarter ending 2020-10-02 was $231.09M, a 14.95% decline year-over-year.
- Exelixis Inc revenues for the quarter ending 2020-07-03 was $259.48M, a 7.99% increase year-over-year.
- Exelixis Inc revenues for the quarter ending 2020-04-03 was $226.91M, a 5.30% increase year-over-year.
- Exelixis Inc revenues for the quarter ending 2019-09-27 was $271.70M.
- Exelixis Inc revenues for fiscal 2017 was $452.48M, a 136.34% increase from fiscal 2016.
- Exelixis Inc revenues for fiscal 2016 was $191.45M.
- Exelixis Inc revenues for fiscal 2016 was $191.45M, a 415.05% increase from fiscal 2016.
- Exelixis Inc revenues for fiscal 2016 was $37.17M.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2020-10-02 | $231.09M 10-Q · filed 2020-11-05 | $490.57M derived: sum of 2 quarters · filed 2020-11-05 | $717.49M 10-Q · filed 2020-11-05 | ||
| 2020-07-03 | $259.48M 10-Q · filed 2020-08-06 | $486.39M 10-Q · filed 2020-08-06 | |||
| 2020-04-03 | $226.91M 10-Q · filed 2020-05-05 | ||||
| 2019-09-27 | $271.70M 10-Q · filed 2020-11-05 | $511.98M derived: sum of 2 quarters · filed 2020-11-05 | $727.47M 10-Q · filed 2020-11-05 | ||
| 2019-06-28 | $240.28M 10-Q · filed 2020-08-06 | $455.76M 10-Q · filed 2020-08-06 | |||
| 2019-03-29 | $215.49M 10-Q · filed 2020-05-05 | ||||
| 2018-06-29 | $186.11M 10-Q · filed 2018-08-01 | $399.83M 10-Q · filed 2018-08-01 | $519.88M derived: sum of 3 quarters · filed 2018-08-01 | $672.39M derived: sum of 4 quarters · filed 2018-08-01 | |
| 2018-03-30 | $213.70M 10-Q · filed 2018-08-01 | $212.35M 10-Q · filed 2018-05-02 | $333.77M derived: sum of 2 quarters · filed 2018-08-01 | $486.28M derived: sum of 3 quarters · filed 2018-08-01 | |
| 2017-12-29 | $120.07M 10-K · filed 2018-02-26 | $272.58M derived: sum of 2 quarters · filed 2018-02-26 | $452.48M 10-K · filed 2018-02-26 | ||
| 2017-09-30 | $152.51M 10-Q · filed 2017-11-01 | $332.40M 10-Q · filed 2017-11-01 | |||
| 2017-09-29 | $152.51M 10-K · filed 2018-02-26 | $251.52M derived: sum of 2 quarters · filed 2018-08-01 | $332.40M derived: sum of 3 quarters · filed 2018-08-01 | $409.99M derived: sum of 4 quarters · filed 2018-08-01 | |
| 2017-06-30 | $99.01M 10-Q · filed 2018-08-01 | $179.90M 10-Q · filed 2017-08-02 | $257.48M derived: sum of 3 quarters · filed 2018-08-01 | ||
| 2017-03-31 | $80.89M 10-Q · filed 2017-05-01 | $158.47M derived: sum of 2 quarters · filed 2018-05-02 | |||
| 2016-12-31 | $77.58M 10-K · filed 2017-02-27 | $191.45M 10-K · filed 2017-02-27 | |||
| 2016-12-30 | $77.58M 10-K · filed 2018-02-26 | $139.78M derived: sum of 2 quarters · filed 2018-02-26 | $176.03M derived: sum of 3 quarters · filed 2018-02-26 | $191.45M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $62.19M 10-K · filed 2018-02-26 | $98.45M derived: sum of 2 quarters · filed 2018-02-26 | $113.87M 10-Q · filed 2017-11-01 | ||
| 2016-07-01 | $36.25M 10-K · filed 2018-02-26 | ||||
| 2016-06-30 | $36.25M 10-Q · filed 2017-08-02 | $51.68M 10-Q · filed 2017-08-02 | |||
| 2016-04-01 | $15.43M 10-K · filed 2018-02-26 | ||||
| 2016-03-31 | $15.43M 10-Q · filed 2017-05-01 | $25.36M derived: sum of 2 quarters · filed 2017-05-01 | $35.22M derived: sum of 3 quarters · filed 2017-05-01 | $43.21M derived: sum of 4 quarters · filed 2017-05-01 | |
| 2016-01-01 | $37.17M 10-K · filed 2018-02-26 | ||||
| 2015-12-31 | $9.94M 10-K · filed 2017-02-27 | $19.79M derived: sum of 2 quarters · filed 2017-02-27 | $27.78M derived: sum of 3 quarters · filed 2017-02-27 | $37.17M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $9.85M 10-K · filed 2017-02-27 | $17.85M derived: sum of 2 quarters · filed 2017-02-27 | $27.23M 10-Q · filed 2016-11-03 | $34.59M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | $7.99M 10-K · filed 2017-02-27 | $17.38M 10-Q · filed 2016-08-03 | $24.73M derived: sum of 3 quarters · filed 2017-02-27 | $31.02M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | $9.39M 10-K · filed 2017-02-27 | $16.74M derived: sum of 2 quarters · filed 2017-02-27 | $23.03M derived: sum of 3 quarters · filed 2017-02-27 | $29.59M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $7.35M 10-K · filed 2016-02-29 | $13.64M derived: sum of 2 quarters · filed 2016-02-29 | $20.21M derived: sum of 3 quarters · filed 2016-02-29 | $25.11M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $6.29M 10-K · filed 2016-02-29 | $12.85M derived: sum of 2 quarters · filed 2016-02-29 | $17.76M 10-Q · filed 2015-11-10 | $22.11M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $6.56M 10-K · filed 2016-02-29 | $11.47M derived: sum of 2 quarters · filed 2016-02-29 | $15.81M derived: sum of 3 quarters · filed 2016-02-29 | $21.28M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $4.91M 10-K · filed 2016-02-29 | $9.25M derived: sum of 2 quarters · filed 2016-02-29 | $14.72M derived: sum of 3 quarters · filed 2016-02-29 | $26.57M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $9.81M derived: sum of 2 quarters · filed 2016-02-29 | $21.67M derived: sum of 3 quarters · filed 2016-02-29 | $31.34M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $5.47M 10-Q · filed 2013-10-30 | $17.32M derived: sum of 2 quarters · filed 2013-10-30 | $26.99M 10-Q · filed 2013-10-30 | $34.80M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $11.86M 10-Q · filed 2013-08-06 | $21.52M 10-Q · filed 2013-08-06 | $29.34M derived: sum of 3 quarters · filed 2015-03-02 | $42.65M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $9.67M 10-Q · filed 2014-05-01 | $17.48M derived: sum of 2 quarters · filed 2015-03-02 | $30.80M derived: sum of 3 quarters · filed 2015-03-02 | $38.61M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $21.13M derived: sum of 2 quarters · filed 2015-03-02 | $28.94M derived: sum of 3 quarters · filed 2015-03-02 | $47.45M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $13.31M 10-Q · filed 2013-10-30 | $21.13M derived: sum of 2 quarters · filed 2013-10-30 | $39.64M 10-Q · filed 2013-10-30 | $132.94M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-06-30 | $7.81M 10-Q · filed 2013-08-06 | $26.32M 10-Q · filed 2013-08-06 | $119.63M derived: sum of 3 quarters · filed 2014-02-20 | $247.90M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-03-31 | $18.51M 10-Q · filed 2013-05-07 | $111.82M derived: sum of 2 quarters · filed 2014-02-20 | $240.09M derived: sum of 3 quarters · filed 2014-02-20 | $272.25M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2011-12-31 | $93.31M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $221.58M derived: sum of 2 quarters · filed 2014-02-20 | $253.74M derived: sum of 3 quarters · filed 2014-02-20 | $289.64M 10-K · filed 2014-02-20 | |
| 2011-09-30 | $128.27M 10-Q · filed 2012-11-07 | $160.43M derived: sum of 2 quarters · filed 2012-11-07 | $196.33M 10-Q · filed 2012-11-07 | $237.10M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-06-30 | $32.16M 10-Q · filed 2012-08-02 | $68.06M 10-Q · filed 2012-08-02 | $108.83M derived: sum of 3 quarters · filed 2013-02-21 | $163.31M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-03-31 | $35.89M 10-Q · filed 2012-05-03 | $76.67M derived: sum of 2 quarters · filed 2013-02-21 | $131.14M derived: sum of 3 quarters · filed 2013-02-21 | $178.74M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2010-12-31 | $40.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $95.25M derived: sum of 2 quarters · filed 2013-02-21 | $142.85M derived: sum of 3 quarters · filed 2013-02-21 | $185.04M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $54.47M 10-Q · filed 2011-10-27 | $102.07M derived: sum of 2 quarters · filed 2011-10-27 | $144.27M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $47.60M 10-Q · filed 2011-08-04 | $89.80M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $151.76M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |